Pulmonary haemorrhage [patf]
abciximab [aapp, imft, phsu]
risk factors [qnco]
Role [socb]
Protamine [aapp, bacs, phsu]
Large [qnco]
Clinical Trials [resa]
Clinical [qlco]
Effectiveness [qlco]
therapy [ftcn]
inhibitors [chvf]
Platelet glycoprotein IIb-IIIa [aapp]
Surface [spco]
Membrane [tisu]
receptor [aapp, rcpt]
Broad [spco]
Range [qnco]
Patients [podg]
ischaemic heart disease [dsyn]
abciximab [aapp, imft, phsu]
Platelet glycoprotein IIb-IIIa [aapp]
receptor [aapp, rcpt]
Associated [qlco]
Improved [qlco]
Long-term [tmco]
Prognosis [hlca]
Patients [podg]
Angioplasty [topp]
Stent placement [topp]
Severe [qlco]
Bleeding [patf]
abciximab [aapp, imft, phsu]
Uncommon [qlco]
Event [evnt]
Severe [qlco]
Pulmonary haemorrhage [patf]
treatment [ftcn]
abciximab [aapp, imft, phsu]
Predisposing Factors [tmco]
Protamine [aapp, bacs, phsu]
Infusion [topp]
Fatal [qlco]
Complication [patf]
